TY - JOUR
T1 - Pharmacotherapy for allergic contact dermatitis
AU - Jacob, Sharon E.
AU - Castanedo-Tardan, Mari Paz
N1 - Expert Opin Pharmacother. 2007 Nov;8(16):2757-74. Review
PY - 2007/11
Y1 - 2007/11
N2 - Allergic contact dermatitis is a highly prevalent, potentially chronic disease, with a significant economic and quality of life impact. Culprit causal allergen(s) can be identified though patch testing, the 'gold-standard' diagnostic method. For most people, identification and subsequent avoidance of their clinically relevant allergens will results in resolution of the dermatitis. However, when an avoidance regimen is not possible, or an allergen is not identified, patients potentially require symptomatic and immunosuppressive therapy to diminish the manifestations of their disease. This article reviews a therapeutic approach to allergic contact dermatitis.
AB - Allergic contact dermatitis is a highly prevalent, potentially chronic disease, with a significant economic and quality of life impact. Culprit causal allergen(s) can be identified though patch testing, the 'gold-standard' diagnostic method. For most people, identification and subsequent avoidance of their clinically relevant allergens will results in resolution of the dermatitis. However, when an avoidance regimen is not possible, or an allergen is not identified, patients potentially require symptomatic and immunosuppressive therapy to diminish the manifestations of their disease. This article reviews a therapeutic approach to allergic contact dermatitis.
KW - Allergic contact dermatitis
KW - Systemic
KW - Topical
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=36048945290&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36048945290&partnerID=8YFLogxK
U2 - 10.1517/14656566.8.16.2757
DO - 10.1517/14656566.8.16.2757
M3 - Review article
C2 - 17956197
SN - 1465-6566
VL - 8
SP - 2757
EP - 2774
JO - Expert Opinion on Pharmacotherapy
JF - Expert Opinion on Pharmacotherapy
IS - 16
ER -